Literature DB >> 22115604

Psychomotor recovery and blood propofol level in colonoscopy when using propofol sedation.

Akira Horiuchi1, Yoshiko Nakayama, Hideyasu Fujii, Yoshihiko Katsuyama, Shigeru Ohmori, Naoki Tanaka.   

Abstract

BACKGROUND: It is commonly recommended that patients refrain from driving for 24 hours after endoscopy for which sedation is given.
OBJECTIVE: The aim of this study was to evaluate psychomotor recovery and blood propofol concentrations after colonoscopy with propofol sedation to determine whether driving might be safe.
DESIGN: A prospective, consecutive study.
SETTING: Municipal hospital outpatients. PATIENTS: This study involved 48 consecutive patients scheduled for colonoscopy with propofol sedation. INTERVENTION: Patient clinical features, psychomotor recovery, and blood concentrations of propofol were assessed. Psychomotor recovery was assessed before colonoscopy and 1 and 2 hours after colonoscopy by using the number connection test and a driving simulator test. MAIN OUTCOME MEASUREMENTS: Clinical features, psychomotor recovery, and blood concentration of propofol.
RESULTS: All patients successfully completed the post-sedation assessments. Although there was a significant difference in results of the number connection test between before colonoscopy and 1 hour after colonoscopy, all number connection test results were within normal limits (<40 seconds). Scores were as follows: mean time (standard deviation) before colonoscopy, 32.2 (2.0) seconds (range 29-36 seconds) versus after colonoscopy, 32.7 (2.0) seconds (range 27-38 seconds); P = .0019. Driving skills had recovered to the baseline levels 1 hour after colonoscopy. Scores were as follows: tracking error (%) before colonoscopy, 45.0 (5.6) versus after colonoscopy, 46.0 (5.5); P = .61; accelerating reaction time in seconds before colonoscopy, 0.65 (0.15) versus after colonoscopy, 0.62 (0.14); P = .40; braking reaction time in seconds before colonoscopy, 0.58 (0.13) versus after colonoscopy, 0.61 (0.13); P = .50. LIMITATIONS: Small sample size, single-center study.
CONCLUSION: Although consistent findings on the number connection test and driving simulation (psychomotor recovery) test are present as early as 1 hour after propofol sedation, a study of additional numbers of patients as well as different patient populations are needed before these results can be universally recommended.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115604     DOI: 10.1016/j.gie.2011.08.020

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  10 in total

1.  Safety and effectiveness of propofol sedation during and after outpatient colonoscopy.

Authors:  Akira Horiuchi; Yoshiko Nakayama; Masashi Kajiyama; Naoyuki Kato; Tetsuya Kamijima; Yasuyuki Ichise; Naoki Tanaka
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

2.  Benefits and limitations of cap-fitted colonoscopy in screening colonoscopy.

Authors:  Akira Horiuchi; Yoshiko Nakayama; Masashi Kajiyama; Naoyuki Kato; Yasuyuki Ichise; Naoki Tanaka
Journal:  Dig Dis Sci       Date:  2012-10-04       Impact factor: 3.199

3.  Post-Anaesthetic Discharge Scoring System to assess patient recovery and discharge after colonoscopy.

Authors:  Lucio Trevisani; Viviana Cifalà; Giuseppe Gilli; Vincenzo Matarese; Angelo Zelante; Sergio Sartori
Journal:  World J Gastrointest Endosc       Date:  2013-10-16

4.  Safety and effectiveness of low-dose propofol sedation during and after esophagogastroduodenoscopy in child A and B cirrhotic patients.

Authors:  Naoki Tanaka; Akira Horiuchi; Yoshiko Nakayama; Yoshihiko Katsuyama; Masatsugu Isobe; Toshifumi Aoyama; Eiji Tanaka; Shigeru Ohmori
Journal:  Dig Dis Sci       Date:  2012-11-21       Impact factor: 3.199

5.  Safety and Recipient Satisfaction of Propofol Sedation in Outpatient Endoscopy: A 24-Hour Prospective Investigation Using a Questionnaire Survey.

Authors:  Yoshihide Kanno; Tetsuya Ohira; Yoshihiro Harada; Shinsuke Koshita; Takahisa Ogawa; Hiroaki Kusunose; Yoshiki Koike; Taku Yamagata; Toshitaka Sakai; Kaori Masu; Keisuke Yonamine; Kazuaki Miyamoto; Megumi Tanaka; Tomohiro Shimada; Fumisato Kozakai; Kazuki Endo; Haruka Okano; Daichi Komabayashi; Takeshi Shimizu; Shohei Suzuki; Kei Ito
Journal:  Clin Endosc       Date:  2020-12-11

Review 6.  Practice guidelines for propofol sedation by non-anesthesiologists: the Korean Society of Anesthesiologists Task Force recommendations on propofol sedation.

Authors:  Hyun Kang; Duk Kyung Kim; Yong-Seon Choi; Young-Chul Yoo; Hyun Sik Chung
Journal:  Korean J Anesthesiol       Date:  2016-08-18

Review 7.  Sedation for routine gastrointestinal endoscopic procedures: a review on efficacy, safety, efficiency, cost and satisfaction.

Authors:  Otto S Lin
Journal:  Intest Res       Date:  2017-10-23

8.  Does propofol mode of administration influence psychomotor recovery time after sedation for colonoscopy: A prospective randomized assessor-blinded trial.

Authors:  Philippe J Van der Linden; Hans Verdoodt; Etienne Métallo; Chantal Plasman; Jean-François Fils; Denis Schmartz
Journal:  Saudi J Anaesth       Date:  2021-09-02

Review 9.  2021 Korean Society of Gastrointestinal Endoscopy Clinical Practice Guidelines for Endoscopic Sedation.

Authors:  Hong Jun Park; Byung-Wook Kim; Jun Kyu Lee; Yehyun Park; Jin Myung Park; Jun Yong Bae; Seung Young Seo; Jae Min Lee; Jee Hyun Lee; Hyung Ku Chon; Jun-Won Chung; Hyun Ho Choi; Myung Ha Kim; Dong Ah Park; Jae Hung Jung; Joo Young Cho
Journal:  Clin Endosc       Date:  2022-02-22

10.  2021 Korean Society of Gastrointestinal Endoscopy Clinical Practice Guidelines for Endoscopic Sedation.

Authors:  Hong Jun Park; Byung-Wook Kim; Jun Kyu Lee; Yehyun Park; Jin Myung Park; Jun Yong Bae; Seung Young Seo; Jae Min Lee; Jee Hyun Lee; Hyung Ku Chon; Jun-Won Chung; Hyun Ho Choi; Myung Ha Kim; Dong Ah Park; Jae Hung Jung; Joo Young Cho
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.